43 results
Page 2 of 3
8-K
EX-1.1
pipbb4u adq5shjfg1z
27 Nov 19
X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class B Warrants
5:18pm
424B5
n7gpxyx4v nf00nb2g
27 Nov 19
Prospectus supplement for primary offering
12:00am
424B5
bho6m4as
25 Nov 19
Prospectus supplement for primary offering
4:19pm
8-K/A
EX-10.8
zy9kqde
13 May 19
Financial Statements and Exhibits
4:58pm
8-K
EX-1.1
jwyzxw 13
15 Apr 19
X4 Pharmaceuticals Prices $85.8 Million Public Offering of Common Stock and Class A Warrants
4:41pm
424B5
574rj4qvyv0rnobclk4
15 Apr 19
Prospectus supplement for primary offering
4:38pm
424B5
3lz7f
12 Apr 19
Prospectus supplement for primary offering
6:05am
8-K
EX-10.8
2ap9crmthjeafr ovbe
13 Mar 19
X4 Pharmaceuticals Completes Merger with Arsanis
5:28pm
S-4/A
74ng69
13 Feb 19
Registration of securities issued in business combination transactions (amended)
4:44pm
S-3
tz1krgh5534s5 3rn
25 Jan 19
Shelf registration
5:04pm
S-4
fqp96tgk2jecj3nrno3w
20 Dec 18
Registration of securities issued in business combination transactions
5:14pm
8-K
EX-2.1
tgbysem7ra8xo8aufec
27 Nov 18
Entry into a Material Definitive Agreement
7:10am
425
EX-2.1
rhejmqt0
27 Nov 18
Business combination disclosure
7:08am